Changes in methadone maintenance therapy during and after pregnancy

Journal of Substance Abuse Treatment

Volumn 41, Issue 4, 2011, Pages 347-353

  Albright, Brittany ^a   de la Torre, Lesley ^a   Skipper, Betty ^a   Price, Sylvia ^a   Abbott, Patrick ^a   Rayburn, William ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Maintenance therapy; Methadone; Pregnancy

Indexed keywords

METHADONE;

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; GESTATIONAL AGE; HUMAN; LONGITUDINAL STUDY; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; METHADONE TREATMENT; OPIATE ADDICTION; PREGNANCY; PREGNANT WOMAN; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; ANALGESICS, OPIOID; COMPUTERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INPATIENTS; METHADONE; OPIATE SUBSTITUTION TREATMENT; OUTPATIENTS; PREGNANCY; SOFTWARE; TIME FACTORS; YOUNG ADULT;

EID: 82455187960     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2011.05.002     Document Type: Article

References (31)

1. Batki S.L., Marion I K.J., Parrino M.W., Woody G.E. Center for Substance Abuse Treatment (CSAT). Medication-assisted treatment for opioid addiction during pregnancy. Medication-assisted treatment opioid addiction in opioid treatment programs. (Treatment improvement protocol (TIP); no. 43) 2005, 211-224. Substance Abuse and Mental Health Services Administration (SAMHSA), Rockville (MD).
2. Cleary B.J., Donnelly J., Strawbridge J.D., Gallagher P.J., Fahey T., Clarke M., et al. Methadone dose and neonatal abstinence syndrome-Systematic review and meta-analysis. Addiction 2010, 105:2071-2084.
3. Department of Health (England) The Scottish Government, Welsh Assembly Government, Northern Ireland Executive. Drug Misuse and Dependence: UK Guidelines on Clinical Management. London 2007.
4. Drozdick J., Berghella V., Hill M., Kaltenbach K. Methadone trough levels in pregnancy. American Journal of Obstetrics and Gynecology 2002, 187:1184-1188.
5. Helmbrecht G., Thiagarajah S. Management of addiction disorders in pregnancy. Journal of Addict Medicine 2008, 2:1-16.
6. Jarvis M.A., Wu-Pong S., Kniseley J.S., Schnoll S.H. Alterations in methadone metabolism during pregnancy. Journal of Addict Disease 1999, 18:51-61.
7. Jones H.E., Johnson R.E., Jasinski D.R., Milio L. Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone. Drug and Alcohol Dependence 2005, 78:33-38.
8. Jones H.E., Johnson R.E., O'Grady K.E. Dosing adjustment in postpartum patients maintained on buprenorphine or methadone. Journal of Addict Medicine 2008, 2:103-107.
9. Jones H.E., Katenback K., Heil S.H., Stine S.M., Colyle M.G., Arria A.M., et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. The New England Journal of Medicine 2010, 363:2320-2331.
10. Jones H.E., Martin P.R., Heil S.H., et al. Treatment of opioid-dependent pregnant women: Clinical and research issues. Journal of Substance Abuse Treatment 2008, 35:245-259.
11. Jones H.E., O'Grady K.E., Malfi D., Tuten M. Methadone maintenance vs. methadone taper during pregnancy: Maternal and neonatal outcomes. The American Journal on Addictions 2008, 17:372-386.
12. Kaltenbach K., Berghella V., Finnegan L. Opioid dependence during pregnancy. Effects and management. Obstetrics and Gynecology Clinics of North America 1998, 21:39-151.
13. Leeman L.M., Brown S., Albright B., Skipper B., Hsi A., Rayburn W.R. Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates. The Journal of Maternal-fetal & Neonatal Medicine 2011, 24:955-959.
14. Lim S., Prasad M.R., Samuels P., Gardner D.K., Cordero L. High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome. American Journal of Obstetrics and Gynecology 2009, 200:70.e1-70.e5.
15. McCarthy J.J., Leamon M.H., Parr M.S., Anania B. High-dose methadone maintenance in pregnancy: Maternal and neonatal outcomes. American Journal of Obstetrics and Gynecology 2005, 193:606-610.
16. Martin P.R., Arria A.M., Fischer G., et al. Psychopharmacologic management of opioid-dependent women during pregnancy. American Journal Addiction 2009, 18:2:148-156.
17. Mattick R.P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 2003, 2:1-17.
18. Minozzi S., Amato L., Vecchi S., Davoli M. Maintenance agonist treatments for opiate dependent pregnant women. Cochrane Database of Systemic Reviews 2008, Issue 2. Art. No.: CD006318. 10.1002/14651858.CD006318.pub2.
19. Nanovskaya T.N., Deshmukh S.V., Nekhayeva I.A., Zharikova O.L., Hankins G.D.V., Ahmed M.S. Methadone metabolism by human placenta. Biochemical Pharmacology 2004, 68:583-591.
20. New South Wales Department of Health National Clinical Guidelines for the Management of Drug Use During Pregnancy, Birth and the Early Development Years of the Newborn 2006, NSW Department of Health, Sydney.
21. Pichini S., Puig C., Zuccaro P., Marchei E., Pellegrini M., Murillo J., et al. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: Preliminary results of the "meconium project". Forensic Science International 2005, 153:59-65.
22. Pond S.M., Kreek M.J., Tong T.G., Raghunath J., Benowitz N.L. Altered methadone pharmacokinetics in methadone-maintained pregnant women. Journal of Pharmacology and Exprimental Therapeutics 1985, 233:1-6.
23. Rettig R.A., Yarmolinsky A. Federal regulation of methadone treatment 1995, National Academies Press, Washington, D.C.
24. Seligman N.S., Almario C.V., Hayes E.J., Dysart K.C., Berghella V., Baxter J.K. Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome. The Journal of Pediatrics 2010, 157:428-433.e1.
25. Seligman N.S., Weiner S.M., Berghella V. Methadone maintenance therapy during pregnancy UpToDate 2009, Accessed on November 9, 2009 from. http://www.uptodate.com.
26. Substance Abuse and Mental Health Services Administration (SAMHSA). (2005). Medication-Assisted Treatment in Opioid Treatment Programs: A Treatment Improvement Protocol (TIP) 43. 054048, 211-224. DHHS Publication No (SMA). Accessed on October 30, 2010.
27. Substance Abuse and Mental Health Services Administration (2007). National Survey on Drug Use and Health: Detailed Tables 770B. Accessed on June 16, 2011 from http://oas.samhsa.gov/NSDUH/2k7NSDUH/tabs/Sect7pcTabs59toll5.htm#Tab7.69A.
28. Swift R.M., Dudley M., DePetrillo P., Camara P., Griffiths W. Altered methadone pharmacokinetics in pregnancy: Implications for dosing. Journal of Substance Abuse 1989, 1:453-460.
29. Wesson D.R., Ling W. The Clinical Opiate Withdrawal Scale (COWS). Journal of Psychoactive Drugs 2003, 35:253-259.
30. Winklbaur B., Kopf N., Ebner N., Jung E., Thaur K., Fischer G. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependency: A knowledge synthesis for better treatment for women and neonates. Addiction 2008, 103:1429-1446.
31. Wolff K., Boys A., Rostami-Hodjegan A., Hay A., Raistrick D. Changes to methadone clearance during pregnancy. European Journal of Clinical Pharmacology 2005, 61:763-768.